Adicet Bio (ACET) Securities - Tradable (2018 - 2020)

Adicet Bio's Securities - Tradable history runs 3 years deep, the most recent figure standing at $15.1 million for Q1 2020.

• In Q1 2020, Securities - Tradable fell 88.88% year-over-year to $15.1 million; the TTM figure through Mar 2020 stood at $15.1 million (down 88.88% YoY), while the FY2019 annual figure was $57.7 million, down 42.86% from the prior year.
• Securities - Tradable for Q1 2020 stood at $15.1 million, down from $57.7 million in the prior quarter.
• The five-year high for Securities - Tradable was $135.9 million in Q1 2019, with the low at $15.1 million in Q1 2020.
• The 3-year median for Securities - Tradable is $97.3 million (2018), against an average of $85.8 million.
• The sharpest annual moves came in 2019 and 2020: Securities - Tradable slumped 42.86% in 2019, then plunged 88.88% in 2020.
• Adicet Bio's Securities - Tradable stood at $101.0 million in 2018, then plunged by 42.86% to $57.7 million in 2019, then plunged by 73.81% to $15.1 million in 2020.
• Business Quant data shows ACET's Securities - Tradable at $15.1 million in Q1 2020, $57.7 million in Q4 2019, and $93.6 million in Q3 2019.